Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 95, Issue 1, 2001, Pages 43-49

  Nagesha, Hadya S ^a,c   Din Syafruddin, ^a,d   Casey, Gerard J ^a,c   Susanti, Augustina I ^b   Fryauff, David J ^b   Reeder, John C ^c   Cowman, Alan F ^c,e  

^a EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^b US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d HASANUDDIN UNIVERSITY   (Indonesia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Chloroquine; dhfr; dhps; Drug resistance; Malaria; Plasmodium falciparum; Pyrimethamine sulfadoxine

Indexed keywords

ARGININE; ASPARTIC ACID; CHLOROQUINE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR; GLUTAMIC ACID; GLYCINE; MULTIDRUG RESISTANCE PROTEIN 1;

ANTIBIOTIC RESISTANCE; ARTICLE; DISEASE CLASSIFICATION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HYPOTHESIS; IN VIVO STUDY; INDONESIA; MAJOR CLINICAL STUDY; MALARIA; MOLECULAR MECHANICS; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; PREDICTION; RECURRENT DISEASE;

INSECTA; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0035724047     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(01)90329-3     Document Type: Article

References (45)

1. Genetic evidence that RI chloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasites
2. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia
3. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia
4. pfmdr1 gene mutation and clinical response to chloroquine in Yaounde, Cameroon
5. Sequence variation in the hydroxymethyldihydropterin pyrophosphokinase: Dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine European
6. Chloroquine-resistant falciparum malaria from Irian Jaya (Indonesian New Guinea)
7. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum
8. Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates
9. Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania
10. In vivo selection for a specific genotype of dihydropteroate synthase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment
11. Evidence for selection for the tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum by chloroquine and amodiaquine
12. Plasmodium falciparum: Detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion
13. Chloroquine resistance of Plasmodium falciparum in West Irian and East Kalimantan
14. Folate metabolism in malaria
15. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum
16. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum
17. In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia
18. Plasmodium falciparum mdr1 mutations and in vivo chloroquine resistance in Indonesia
19. Prolonged incubation improves the micro-scale in-vitro test for drug sensitivity of Plasmodium falciparum
20. Pyrimethamine-sulfadoxine still effective against Plasmodium falciparum in Jayapura, Irian Jaya: RI-type resistance in 2 of 18 patients
21. Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: Correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes
22. Efflux of chloroquine from Plasmodium falciparum: Mechanism of chloroquine resistance
23. Plasmodium falciparum: Susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren
24. The use of medicated salt in an antimalaria campaign in West New Guinea
25. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria
26. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance
27. Malaria situation in several villages around Timika, south central Irian Jaya, Indonesia
28. pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum
29. Whole blood concentrations of chloroquine and desethylchloroquine during and after treatment of adult patients infected with Plasmodium vivax, Plasmodium ovale or Plasmodium malariae
30. Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi
31. Complex polymorphisms in an ∼330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa
32. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum
33. Mutations of dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum
34. Allelic exchange at the endogeneous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria
35. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential use in epidemiological studies
36. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins
37. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization
38. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: Selective pressure for resistance is a function of long elimination half-life
39. More on the efficacy of antifolate antimalarial combination in Africa
40. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross
41. Malaria in the South-East Asia Region
42. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine
43. Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: Evidence for quinine resistance